Trump Asks Collins to Stay On at NIH

Update: The president has extended his request from staying on as NIH director during the transition to a formal appointment.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, NATIONAL HUMAN GENOME RESEARCH INSTITUTEUpdate (June 7): NIH Director Francis Collins will keep his job, the White House announced today. Collins tweeted: “Honored to be selected by @POTUS to continue as #NIH Director. I consider it a privilege to continue to lead this noble enterprise.”

According to STAT News, “[t]he continuation announced Tuesday isn’t a guarantee that Collins will remain in place for any specific length of time, spokespeople for both the White House and the NIH confirmed.”

Republican and Democratic lawmakers praised the appointment. “This is good news for the country and one of President Trump’s best appointments,” Senator Lamar Alexander (R-TN), the chairman of the Senate Health, Education, Labor and Pensions Committee, tells The Hill in a statement. (Update by Kerry Grens)

President-elect Donald Trump has asked National Institutes of Health Director Francis Collins to stay on through his administration’s transition into office, Science reported. “We just learned that Dr. Collins has been held over by the Trump administration,” an NIH spokesperson said in a statement quoted by Science. “We have no additional details at this time.”

Whether Trump will formally appoint Collins has yet to be seen. According to The Washington Post, “if he is not asked to stay permanently ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies